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Depletion of ATP is known to inhibit glucose transport in human erythrocytes, but the kinetic mechanism of this effect 
is controversial. Selective ATP depletion of human erythrocytes by 10/~g/ml A23187 in the presence of extracellular calci- 
um inhibited 3-O-methylglucose influx noncompetitively and efflux competitively. ATP depletion also decreased the abili- 
ty of either equilibrated 3-O-methylglucose or extracellular maltose to inhibit cytochalasin B binding in intact cells, 
whereas neither total high-affinity cytochalasin B binding nor its Ka was affected. Under the one-site model of hexose 
transport these data indicate that ATP depletion decreases both the affinity of the inward-facing lucose carrier for sub- 
strate and its ability to reorient outwardly in intact cells. 
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1. INTRODUCTION 
Depletion of erythrocyte ATP by treatment with 
the ionophore A23187 and calcium to activate 
CaZ+-ATPase lowers rates of hexose uptake, 
reflecting a decrease in the [/'max of net glucose in- 
flux with no change in the Km [1]. Other models of 
ATP depletion in intact cells or resealed ghosts 
[2-5] have confirmed an inhibitory effect of ATP 
depletion, but often with conflicting kinetic 
results. Reasoning that the transport effects of 
ATP depletion have the most physiologic relevance 
in intact cells, and that A23187/calcium treatment 
is the most specific method for depleting ATP [1], 
I have used these conditions to define the effects of 
ATP depletion on the transport mechanism under 
the one-site or alternating conformation model of 
transport [6]. 
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2. EXPERIMENTAL 
2.1. Cell, buffer, and ghost preparation 
Freshly drawn human blood was anticoagulated with heparin 
(16.7 U/ml  blood) and prepared for all subsequent studies as 
described by Jacquez [1] in a balanced salt solution containing 
60 mM NaCI, 75 mM KC1, 1 mM MgClz, 201zM CaCI2 and 
10 mM Tris, pH 7.4. 
2.2. Hexose transport assays 
The net influx of 3-O-[methyl-14C]methylglucose was 
measured as described [7] at 0.01, 0.25, 0.5, 1.0, 2.0 and 
4.0 mM 3-O-methylglucose. 
Kinetic measurements of zero-trans efflux of 3-0- 
methylglucose were initiated by equilibrating 0.8 ml of 20% 
erythrocytes for 30 min at 37°C with labeled and unlabeled 
3-O-methylglucose (0.5, 1, 2, 4 and 8 mM) in the presence or 
absence of A23187. The cells were pelleted in a microfuge, the 
supernatant was aspirated, the tube containing the cell pellet 
was cooled on ice, and duplicate 10/zl aliquots of packed cells 
were removed to a culture tube also on ice. The efflux assay was 
started by adding 1 ml of ice-cold buffer and terminated by 
vigorously adding 3 ml of ice-cold 'stop' solution containing 
10 ,uM cytochalasin B. The cells were pelleted and the radioac- 
tivity of 0.5 ml of supernatant counted. The time of efflux was 
varied to maintain extracellular radioactivity at the termination 
of the assay to less than 20°7o of that present after 30 min at 
37°C. Correction was made in each assay for label which was 
extracellular at the beginning of the assay by subtracting the ex- 
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tracellular radioactivity measured when stop solution was add- 
ed to cells before diluent. 
Transport rates for both net influx and efflux were normal- 
ized to the equilibrium space of 3-O-methylglucose for that 
sample. Michaelis constants were determined using the 
nonlinear least-squares method of Wilkinson [8]. 
2.3. f H]Cytochalasin B binding 
Cytochalasin B binding to intact erythrocytes was measured 
as in [9] in the presence of 100,uM cytochalasin E as well as a 
range of cytochalasin B concentrations (250, 125, 62.5 or 
10 nM) containing 62.5 nCi [4-3H]cytochalasin B. The inhibi- 
tion of 10 nM [3H]cytochalasin B binding by several concentra- 
tions of either maltose or 3-O-methylglucose (0, 12.5, 25, 50, 
100 mM) was determined under the above conditions and ex- 
pressed as an apparent inhibitory constant (K0 according to 
Gorga and Lienhard [6]. 
2.4. Other assays 
Total glutathione content was measured by the method of 
Hissen and Hilf [10]. Efflux of 35SO42- from preloaded cells was 
measured as described [7]. Data are expressed asmeans _+ SE 
and compared using the Student's t-test for paired values. 
3. RESULTS 
Prel iminary studies (not shown) confirmed the 
initial observations of Jacquez [1] that treatment 
of erythrocytes with 10/tg/ml A23187 inhibited 
tracer 3-O-methylglucose uptake by 50-60°70 
within 30 min, and that this effect was completely 
reversed by metabolic repletion with 5 mM ino- 
sine, 5 mM pyruvate, 5 mM adenine, and 10 mM 
glucose for 1 h at 37°C followed by washes and the 
transport  assay. The specificity of A23187 treat- 
ment for hexose transport was confirmed by 
measuring its effects on sulfate efflux and GSH 
content under the same experimental conditions. 
Neither rates of sulfate efflux nor intracellular 
GSH content measured at 30°C and at an ex- 
tracellular pH of 7.4 were affected by pretreatment 
with 10/~g/ml A23187 (not shown). 
In kinetic transport studies, A23187 treatment 
halved the Vmax of net 3-O-methylglucose influx, 
without an appreciable ffect on the Km (table 1). 
On the other hand, under similar conditions of cell 
number,  buffer composit ion, and temperature of 
the transport assay (3-5 ° C), A23187 approximate- 
ly doubled the Km of net efflux, without affecting 
the Vmax (table 1). 
Again under the same conditions, A23187 treat- 
ment had no significant effect on Ka or total 
specific binding of cytochalasin B to the glucose 
carrier in intact cells (table 1). However, A23187 
Table 1 
Effects of ATP depletion on transport kinetics and cytochalasin 
B binding 
Measurement Control p A23187 N 
treatment 
Net influx 3 
gm 1.3 ± 0.1 NS 1.1 ± 0.1 
Vmax 3.7 ± 0.3 <0.02 2.0 ± 0.2 
Net efflux 9 
Km 4.4 _+ 1.0 <0.02 10.5 _+ 1.6 
Vmax 15.7 ± 3.6 NS 17.1 ± 3.4 
Cytochalasin B 
binding 
Kd 137 ± 11 NS 138 ± 12 4 
Bo 5.2 _+ 0.4 NS 5.5 ± 0.3 4 
3-O-Methylglucose 
-K i  15 ± 4 <0.01 32 _+ 3 7 
Maltose- K~ 24 ± 3 <0.01 72 _+ 8 5 
Erythrocytes at20% hematocrit were incubated for 30 rain at 
37°C with or without 10/zg/ml A23187 followed by the 
appropriate assay as described in section 2. N, number of 
experiments; p, statistical significance. Parameter units: Km 
(mM); Vmax (mol-l' l-I 's-l); Kd (nM); B0 (pmol/ml packed 
cells); Ki (raM) 
treatment doubled the apparent Ki of equil ibrated 
3-O-methylglucose for the carrier, assessed by the 
abil ity of the sugars to inhibit cytochalasin B 
binding (table 1). The ability of extracellular 
maltose to inhibit cytochalasin B binding was even 
more strongly decreased by A23187 treatment 
(table 1). 
4. DISCUSSION 
Treatment of freshly prepared human 
erythrocyte with the calcium ionophore A23187 in 
the presence of extracellular calcium depletes 
cellular energy stores, primari ly in the form of 
ATP ,  resulting in decreased rates of hexose 
transport [1]. As shown initially by Jacquez [1], 
and confirmed herein, the effects of A23187 on 
hexose entry are completely restored by metabolic 
repletion. The effect of A23187 treatment also ap- 
pears to be selective for hexose transport,  since 
under identical incubat ion condit ions neither 
sulfate efflux nor GSH content was affected in the 
present studies. Bursaux et al. [11] similarly found 
no effect of several different methods of ATP  
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deplet ion on erythrocyte sulfate eff lux at an ex- 
tracel lular pH of  7.2 or greater. 
The initial f indings of  Jacquez [1] that A23187 
treatment lowers the maximal  rate of  glucose entry 
without affecting aff inity for the sugar were con- 
f i rmed in the present work using a non- 
metabol izable glucose analog, 3-O-methylglucose 
(table 1). It was also found that the inhibit ion of  
3-O-methylglucose exit by A23187 treatment was 
due to a fall in the Km without an effect on the Vmax 
(table 1). As noted by Krupka  and Dev6s [12], 
under the one-site or alternating conformat ion  
model  of  t ransport  [6,12], such decreased aff inity 
at the inward-facing substrate-binding site (i.e. 
competi t ive inhibit ion) will necessari ly produce the 
noncompet i t ive inhibit ion of  entry observed. 
Whereas cytochalasin B is a competit ive in- 
h ibi tor  of  hexose exit [13], neither its aff inity for 
the inward- fac ing carrier nor its total  binding was 
af fected by A23187 treatment (table 1). On the 
other hand, the abi l i ty of  3-O-methylglucose 
equi l ibrated with both sides of  the membrane to in- 
hibit cytochalasin B binding was diminished by 
A23187 treatment (table 1). This is consistent with 
the observat ion by Jacquez [1] that A23187 treat- 
ment prevented the expected inhibit ion of  
cytochalasin B photolabel ing by even high concen- 
trat ions of  D~glucose in resealed ghosts, while 
cytochalasin B photolabel ing itself was little af- 
fected. Possible explanat ions for the dif ferent ef- 
fects of  A23187 treatment on substrate and 
cytochalas in B binding are that the binding sites 
for substrate and cytochalasin B on the inward- 
facing carrier are not identical [13], or that a con- 
format iona l  change in the carrier induced by 
A23187 treatment selectively blocks substrate 
binding.  
Maltose does not enter erythrocytes [7,14] and 
its d isplacement of  internal ly bound cytochalasin B 
provides strong support  for the one-site model  of  
t ransport .  The decreased abi l i ty of  extracel lular 
maltose to inhibit cytochalasin B binding (table 1) 
further suggests that the carrier in A23187-treated 
cells has a decreased capacity to reorient outwardly 
and bind substrate. The combined transport  and 
cytochalasin B-binding data are compat ib le with 
the not ion that ATP  deplet ion affects both the 
abi l i ty of  the inward-facing carrier to bind 
substrate, and to reorient to its outward-facing 
form. 
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